Office BG 06

Jia Sun, Ph.D.

Analyst

icon linkedin
Jia Sun

Bio

Jia Sun, Ph.D.is an Analyst on the Public Equity team and joined OrbiMed in 2022. Prior to joining OrbiMed, he was a Biotech Analyst in public and private equities at Verition Fund Management. Previously, Jia was a Venture Investor at 6 Dimensions Capital in Boston focusing on early-stage biotech investment. Before transitioning to investing, he was an Engagement Manager with McKinsey & Company in Los Angeles. Jia holds a Ph.D. in Chemical Biology and an MA in Statistics from The University of Michigan, Ann Arbor.

img img img img img img img img img